跳至主要内容

Standard Operating Guide for Nonclinical Data Exchange

 


I. Overview

The Nonclinical Data Exchange Standard is a guideline for standardizing and unifying the exchange of nonclinical experimental data, aiming to improve data sharing and interoperability. This operation guide will guide users to perform operations on standardized data elements, data storage formats, data transmission protocols, data security, data integrity, data readability, data scalability and data compliance.

2. Standardized data elements

1. Define standardized data elements: In data exchange, standardized data elements need to be defined, including experimental types, experimental animals, administration methods, observation indicators, etc.

2. Unified naming and coding: Develop unified naming and coding rules for each data element to ensure the consistency of data elements in data exchange.

3. Develop a data element dictionary: Establish a data element dictionary to clarify the meaning, scope and usage of each data element.

3. Data storage format

1. Choose a common data storage format: It is recommended to use a common data storage format that complies with international standards, such as XML, CSV or JSON.

2. Define a structured data model: Based on the characteristics of the experimental data, design a structured data model to facilitate data organization and storage.

3. Ensure data readability and parsability: Use clear data structures and tags to ensure data readability and parsability.

4. Data transmission protocol

1. Choose a common data transmission protocol: It is recommended to use common protocols such as HTTP or FTP for data transmission.

2. Define API interface: According to business needs, define API interface to realize automatic transmission and acquisition of data.

3. Ensure data transmission efficiency and security: optimize transmission methods, improve data transmission efficiency, and ensure security during data transmission.

5. Data Security

1. Ensure network security: Ensure the network security of data by using encryption technology, access control, firewalls and other measures.

2. Data privacy protection: Develop strict data usage regulations to ensure the privacy and confidentiality of experimental data.

3. Data backup and recovery: Back up data regularly and develop corresponding recovery strategies to prevent data loss.

6. Data integrity

1. Design a complete data collection process: To ensure the integrity of the data, the entire process from experimental design to data collection, sorting and analysis needs to be strictly controlled.

2. Data verification and verification: Verify and verify the data to ensure the accuracy and completeness of the data.

3. Data deduplication and conflict resolution: Deduplication and resolution of possible duplicate data or conflicting data.

7. Data readability

1. Use clear data formats and tags: To ensure the readability of data, you need to adopt clear data formats and tags to make it easy for other users to understand and use the data.

2. Provide necessary data annotations and documentation: Provide necessary annotations and documentation for the data so that other users can understand the meaning and context of the data.

3. Data visualization: Improve the readability and understandability of data through data visualization technology.

8. Data scalability

1. Design scalable data structures: To ensure data scalability, you need to design scalable data structures to adapt to future data growth and changes.

2. Adopt open data formats and protocols: Adopt open data formats and protocols to adapt to future changes in technology and needs.

3. Consider future business needs and development trends: When formulating standards, future business needs and development trends need to be considered in order to adapt to future changes.

9. Data Compliance

1. Comply with relevant laws, regulations and ethical norms: In non-clinical data exchange, it is necessary to comply with relevant laws, regulations and ethical norms to ensure data compliance.

2. Develop internal policies and regulations: Develop internal policies and regulations to standardize the collection, use and processing of data and ensure data compliance.

评论

此博客中的热门博文

Medicilon and Binhui Biopharmaceutical Have Reached a Strategic Collaboration to Jointly Draw a New Blueprint for the Development of New Biological Drugs

  On March 18, Medicilon and Binhui Biopharmaceutical (Binui Bio) announced a strategic collaboration.  The two parties will work together to jointly explore the possibilities in cutting-edge fields such as oncolytic viruses, nucleic acid drugs and protein drugs. Gather and Work Together to Create Advantages      Facilitate the Research and Development of Oncolytic Viruses, Nucleic Acids, Proteins and Other Drugs As a one-stop biopharmaceutical comprehensive preclinical R&D service CRO, Medicilon has been developing and accumulating for 20 years, always adhering to the spirit of innovation, and has successfully constructed bi/multi-specific antibodies,  ADCs ,  mRNA vaccines ,  small nucleic acid drugs ,  PROTAC , and  CGT technical service platform  that have helped 421 INDs obtain clinical approval.  It is this outstanding achievement that has earned Medicilon wide recognition in the industry and laid a solid foundation f...

A Nickel-Catalyzed Reductive Alkylation of Aryl Bromides and Chlorides for Sp3-Sp2 Bond Formation

  In 2012, a nickel-catalyzed reductive alkylation method of aryl bromides and chlorides was reported. Under the optimized conditions, a variety of aryl and vinyl bromides as well as active aryl chloride can be reductively coupled with alkyl bromides in high yields. The protocols were highly functional-group tolerant and the reactions were not air or moisture sensitive. The reaction showed different chemoselectivity than conventional cross-coupling reactions. Substrates bearing both anelectrophilic and nucleophilic carbon resulted in selective coupling at the electrophilic carbon (R-X) and no reaction occurred at the nucleophilic carbon (R-[M]). The 2010 Nobel Prize in Chemistry was awarded for the Pd-catalyzed cross-coupling, and in the past decade the progress in cross-coupling has not only had a significant impact on academic research but has also influenced the industrial synthetic application. The transition-metal-catalyzed union of nucleophilic organo-boronic acids with elect...

The Launch Meeting was Held by Medicilon and DAC Biotech of the Contract Research on ADC Preclinical Study

  Chuansha, Shanghai, Nov. 8th, 2019 — Medicilon held the launch meeting with Hangzhou DAC Biotech Co., Ltd to initiate the   preclinical study   of the antibody-drug-conjugate (ADC)  DXC005, including the   pharmacology study ,   DMPK study   and the   safety evaluation . Medicilon has previously completed integrated  preclinical research  on ADC drugs cooperating with DAC Biotech and other companies. Two of them has been approved by NMPA and entered Phase I clinical trials. About Hangzhou DAC Biotech Co., Ltd Hangzhou DAC Biotech, Co., Ltd was officially registered in HEDA Area, Hangzhou City, Zhejiang Province, China around the end of Year 2012, and is located nearby the bank of beautiful Qiantang River. The company focuses on developing conjugate of monoclonal antibody and small molecular cytotoxic drug, both of which are banded together with smart linkers. About Antibody-Drug-Conjugate (ADC) ADCs ...